Latest Developments in Kidney Disease Treatment The field of nephrology has witnessed remarkable advancements in recent years, aimed at enhancing patient care and boosting the efficacy of available treatments. Below are some of the most prominent developments: 1. Updating the Model List of Essential Medicines The World Health Organization (WHO) has updated its Model List of Essential Medicines to include new drugs that improve the effectiveness of kidney disease treatment. This includes the addition of Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors, such as Empagliflozin, Canagliflozin, and Dapagliflozin. These are used as second-line treatments for adults with Type 2 Diabetes. Beyond managing blood sugar levels, these medications have demonstrated significant benefits in protecting kidney function and slowing the progression of Chronic Kidney Disease (CKD). 2. Combating Antimicrobial Resistance (AMR) United Nations member states have adopted a new political declaration aimed at scaling up efforts to combat antimicrobial resistance, which poses a major threat to modern medicine. This initiative is a crucial step in safeguarding the efficacy of current kidney treatments, especially given the heavy reliance on antibiotics for treating urinary tract infections (UTIs) and other kidney-related infections. Summary These developments reflect the global medical community's commitment to improving kidney disease management strategies by updating pharmacological guidelines and addressing emerging health challenges. These initiatives are expected to enhance the quality of healthcare provided to patients and reduce long-term complications associated with kidney disease. Prepared by: Dr. Taqa Hazim Abdullah AL_mustaqbal University is the first university in Iraq